Management of γ-hydroxybutyrate intoxication and withdrawal

Affiliations

¹ British Columbia Centre on Substance Use (Weaver, Fairbairn); Department of Medicine (Weaver, Ickowicz, Fairbairn), University of British Columbia, Vancouver, BC v.weaver@alumni.ubc.ca.
² British Columbia Centre on Substance Use (Weaver, Fairbairn); Department of Medicine (Weaver, Ickowicz, Fairbairn), University of British Columbia, Vancouver, BC.

Victoria K Weaver et al. CMAJ. 2023.

. 2023 Jun 5;195(22):E786.

doi: 10.1503/cmaj.221564.

¹ British Columbia Centre on Substance Use (Weaver, Fairbairn); Department of Medicine (Weaver, Ickowicz, Fairbairn), University of British Columbia, Vancouver, BC v.weaver@alumni.ubc.ca.
² British Columbia Centre on Substance Use (Weaver, Fairbairn); Department of Medicine (Weaver, Ickowicz, Fairbairn), University of British Columbia, Vancouver, BC.

No abstract available

Conflict of interest statement

Competing interests: None declared.

1. Tay E, Lo WKW, Murnion B. Current insights on the impact of gamma-hydroxybutyrate (GHB) abuse. Subst Abuse Rehabil 2022;13:13–23. - PMC - PubMed
1. Snead OC, III, Gibson KM. Gamma-hydroxybutyric acid. N Engl J Med 2005;352:2721–32. - PubMed
1. Haroz R, Farmer BM. γ-hydroxybutyric acid (γ-hydroxybutyrate). In: Nelson LS, Howland MA, Lewin NA, et al.., editors. Goldfrank’s Toxicologic Emergencies, 11e. New York: McGraw-Hill Education; 2019.
1. Kamal RM, van Noorden MS, Wannet W, et al. . Pharmacological treatment in γ-hydroxybutyrate (GHB) and γ-butyrolactone (GBL) dependence: detoxification and relapse prevention. CNS Drugs 2017;31:51–64. - PubMed
1. Freeman G, Siefried KJ, Roberts DM, et al. . Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: a case series. Drug Alcohol Rev 2023;42:27–32. - PubMed